2. Academic Validation
  3. New Cyclic Lipopeptide Compounds for Efficiently Inhibiting Cellular Inflammation and Collagen-Induced Arthritis in Mice

New Cyclic Lipopeptide Compounds for Efficiently Inhibiting Cellular Inflammation and Collagen-Induced Arthritis in Mice

  • J Med Chem. 2025 Sep 25;68(18):19767-19780. doi: 10.1021/acs.jmedchem.5c02095.
Yanni Ma 1 2,  Xu Cao 1,  Xiaoli Jin 1,  Lan Huang 1,  Dejia Zeng 1,  Zijing Xia 3,  Yi Liu 4,  Shufang Liang 1
Affiliations

Affiliations

  • 1 Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, No.17, Third Section of Renmin South Road, Chengdu 610041, China.
  • 2 Key Laboratory of Natural Products, Henan Academy of Sciences, No. 58, Hongzhuan Road, Zhengzhou 450002, China.
  • 3 Department of Rheumatology, West China Hospital, Sichuan University, Chengdu 610041, China.
  • 4 College of Chemical Engineering, Sichuan University of Science & Engineering, Zigong 643000, China.
PMID: 40923559 DOI: 10.1021/acs.jmedchem.5c02095
Abstract

Rheumatoid arthritis (RA) is a systemic autoimmune disease, and a large number of patients do not respond well to existing treatment strategies. Our previous report has discovered that the cyclic Lipopeptide (CLP) daptomycin (DAP) has a good suppressive arthritis activity in mice. In this study, we have designed and synthesized five novel DAP-derived CLPs by structural optimization on the loop of DAP and further studied their anti-RA effects in vitro and in vivo. Especially, CLP-d2 has better anti-RA effect than DAP due to its better pharmacokinetic parameters and peptide stability. Mechanistically, CLP-d2 effectively reduces the secretion of inflammatory factors (IL-6, TNF-α, and IL-1β) and inhibits the expression of the related proteins in NF-κB and MAPK signaling pathways, thus reducing mouse joint swelling and bone erosion and retarding arthritis progression. Our findings support the potential druggability of DAP-derived CLPs for treatment of RA.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z